Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Alzheimers Dement. 2017 Dec 7;14(2):121–129. doi: 10.1016/j.jalz.2017.10.009

Figure 2.

Figure 2

Prevalence (in millions) of Alzheimer’s disease preclinical and clinical disease states in the United States in 2017 by single year of age. Note: The prevalence of MCI (due to AD) includes persons with MCI who have both amyloidosis and neurodegeneration, and also persons with MCI who have only neurodegeneration.